Amber Robers, NP
Family · Gilbert, AZNPI 1770021735
Payments from drug & device makers
Across 126 payments — averaging $14.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$138
- Novo Nordisk$91
- Boehringer Ingelheim$87
- Abbott$41
- Currax Pharmaceuticals LLC$41
- plus $255 from 13 others
What the payments were for
- Food & beverage$1,786100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 86 | $1,134 |
| Lilly USA, LLC | 9 | $138 |
| Novo Nordisk | 6 | $91 |
| Boehringer Ingelheim | 4 | $87 |
| Abbott | 3 | $41 |
| Currax Pharmaceuticals LLC | 3 | $41 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Johnson & Johnson | 1 | $25 |
| Dexcom, Inc. | 1 | $25 |
| Impulse Dynamics (USA) Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $20 |
| Boston Scientific | 1 | $18 |
| GSK | 1 | $17 |
| Pfizer | 1 | $16 |
| Lucid Diagnostics Inc. | 1 | $14 |
| Shield Therapeutics Inc | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$1,786 in reported general payments places this provider in the 80th percentile of 4,119 family providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $505 |
| Ondansetron OdtOndansetron | 11 | $395 |
| Pantoprazole Sodium | 22 | $309 |
| Omeprazole | 15 | $184 |
| Testosterone Cypionate | 11 | $179 |
| Lisinopril | 21 | $178 |
| Levothyroxine Sodium | 32 | $178 |
| Atorvastatin Calcium | 18 | $164 |
| Montelukast Sodium | 19 | $157 |
| Trazodone Hcl | 25 | $135 |
| Methylprednisolone | 21 | $132 |
| Alprazolam | 21 | $105 |
| ClopidogrelClopidogrel Bisulfate | 13 | $100 |
| Metoprolol Tartrate | 14 | $76 |
| Amlodipine Besylate | 15 | $74 |
Paid to pharmacies, not to this prescriber.
Other family in Gilbert
- Celeste FineGilbert$82K
- Rechelle TrejoGilbert$34K
- Jonathan HenriquezGilbert$26K
- Arin LamoureauxGilbert$17K
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Susan SarabiaSun City West$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.